Prognostic value of immunotherapy-induced organ inflammation assessed on 18FDG-PET in patients with metastatic non-small cell lung cancer.
Paper of the Month November 2022
October 25, 2022
Archived
October 25, 2022
Paper of the Month November 2022
Prognostic value of immunotherapy-induced organ inflammation assessed on 18FDG-PET in patients with metastatic non-small cell lung cancer.